Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Organisation › Details

BioNTech (Group)

BioNTech is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The company combines all building blocks for individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen receptors and T-cell receptor-based products to novel checkpoint immunomodulators. BioNTech’s approach is validated by five top-tier corporate partnerships with Genentech, Genmab, Eli Lilly and Company, Sanofi and Bayer Animal Health. Founded in 2008, BioNTech’s financial shareholders include the MIG Fonds, Salvia and the Strüngmann Family Office, with the Strüngmann Family Office as the majority shareholder. *

 

Period Start 2008-01-01 established
  Predecessor University of Mainz (Johannes Gutenberg University)
Products Industry cancer immunotherapy (immuno-oncology, I-O)
  Industry 2 cancer test
Persons Person Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH)
  Person 2 Pötting, Sierk (BioNTech 201409– CFO before Sandoz Inc/Novartis + McKinsey)
     
Region Region Mainz
  Country Germany
  Street 12 An der Goldgrube
  City 55131 Mainz
  Tel +49-6131-9084-0
    Address record changed: 2018-07-24
     
Basic data Employees D: 101 to 500 (2014-10-01)
     
    * Document for �About Section�: BioNTech AG. (10/4/17). "Press Release: BioNTech Manufacturing Subsidiary, Eufets, Becomes BioNTech Innovative Manufacturing Services". Mainz.
     
   
Record changed: 2018-01-04

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

More documents for BioNTech (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translationl Medicine 2018 Würzburg Germany 600x100px




» top